Ian B. Li
Senior Associate
Cancer
1315 Capital
New Zealand
Biography
Ian Li joined 1315 Capital in 2015, after spending 4 years as a healthcare management and strategy consultant, most recently at Capgemini Consulting. Ian has worked with commercial executives from top pharmaceutical companies on implementing large scale strategic initiatives, with projects spanning market access, product launch, healthcare reform readiness, and engagement of integrated health network (IHN) customers. Prior to consulting, Ian also had experience working at Stryker Orthopaedics in the quality engineering department. Ian received a BSc in Biomedical Engineering from Duke University, with a minor in Economics.
Research Interest
Cancer
